Amgen Inc.
439.26USD
-8.0200 (-1.79%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on AMGN.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $5.79▲ | $5.74 | 2 | 3 |
| Next quarter | $5.77▲ | $5.77 | 4 | 1 |
| Current year | $23.03▲ | $22.34 | 3 | 3 |
| Next year | $24.49▲ | $23.46 | 7 | 1 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $5.62 | $6.29 | +0.67 (+12.0%) |
| 2026-03-31 | $4.77 | $5.15 | +0.38 (+8.0%) |
| 2025-12-31 | $4.73 | $5.29 | +0.56 (+11.9%) |
| 2025-09-30 | $5.01 | $5.64 | +0.63 (+12.5%) |
435 ratings from 43 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Oppenheimer | Maintained | Outperform | $450 $480 | Oct 23, 2026 |
| Barclays | Maintained | Equal-Weight | $380 $400 | Oct 21, 2026 |
| Guggenheim | Maintained | Neutral | $388 $378 | Oct 13, 2026 |
| BMO Capital | Maintained | Market Perform | $450 $415 | Oct 12, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $435 $430 | Oct 12, 2026 |
| UBS | Maintained | Buy | $430 $470 | Oct 9, 2026 |
| RBC Capital | Maintained | Outperform | $400 $430 | Oct 8, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $400 $440 | Oct 8, 2026 |
| Truist Securities | Maintained | Hold | $362 $380 | Oct 7, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $362 $359 | Oct 7, 2026 |
| Scotiabank | Maintained | Sector Outperform | $450 $500 | Sep 29, 2026 |
| HSBC | Downgraded from Buy | Hold | $445 $425 | Sep 10, 2026 |
| BMO Capital | Downgraded from Outperform | Market Perform | $450 | Sep 8, 2026 |
| Cantor Fitzgerald | Reiterated | Neutral | $400 | Sep 8, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $400 $435 | Sep 4, 2026 |
| Piper Sandler | Maintained | Overweight | $427 $457 | Aug 20, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $351 $362 | Aug 19, 2026 |
| Argus Research | Maintained | Buy | $375 $460 | Aug 19, 2026 |
| Mizuho | Maintained | Neutral | $303 $352 | Aug 18, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $350 $400 | Aug 18, 2026 |
| Barclays | Maintained | Equal-Weight | $360 $380 | Aug 14, 2026 |
| Guggenheim | Maintained | Neutral | $343 $388 | Aug 10, 2026 |
| Citigroup | Maintained | Neutral | $345 $405 | Aug 7, 2026 |
| Bernstein | Maintained | Market Perform | $335 $345 | Aug 6, 2026 |
| Baird | Maintained | Underperform | $215 $230 | Aug 5, 2026 |
114 filings from 22 insiders · 32 buy / 4 sell over 6m
Officers and directors of AMGN, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| KHOSLA RACHNAOfficer | Exercise | 1.3k | $162.60 | $204k | Aug 13, 2026 |
| KHOSLA RACHNAOfficer | Sell | 3.3k | $412.57 | $1.35M | Aug 13, 2026 |
| ISHRAK OMAR SYEDDirector | Grant | 85 | — | — | Aug 7, 2026 |
| DRAKE MICHAEL VDirector | Grant | 63 | — | — | Aug 7, 2026 |
| BUSCH MATTHEW C.Officer | Grant | 730 | — | — | Aug 7, 2026 |
| HOLLEY CHARLES M JRDirector | Grant | 103 | — | — | Aug 7, 2026 |
| GRYGIEL NANCY AOfficer | Exercise | 3.0k | $177.31 | $527k | Aug 6, 2026 |
| MILLER DEREKOfficer | Exercise | 3.9k | $162.60 | $660k | Aug 6, 2026 |
| GRYGIEL NANCY AOfficer | Sell | 3.0k | $402.16 | $1.19M | Aug 6, 2026 |
| MILLER DEREKOfficer | Sell | 3.9k | $402.54 | $1.57M | Aug 6, 2026 |
| AUSTIN WANDA MDirector | Grant | 665 | — | — | May 19, 2026 |
| DRUKER BRIAN JDirector | Grant | 665 | — | — | May 19, 2026 |
| ISHRAK OMAR SYEDDirector | Grant | 665 | — | — | May 19, 2026 |
| DRAKE MICHAEL VDirector | Grant | 665 | — | — | May 19, 2026 |
| KLOTMAN MARY EDirector | Grant | 665 | — | — | May 19, 2026 |
| HOLLEY CHARLES M JRDirector | Grant | 665 | — | — | May 19, 2026 |
| ECKERT ROBERT ANDREWDirector | Grant | 665 | — | — | May 19, 2026 |
| MILES AMY EDirector | Grant | 665 | — | — | May 19, 2026 |
| KULLMAN ELLEN JAMISONDirector | Grant | 665 | — | — | May 19, 2026 |
| GARLAND GREGORY C.Director | Grant | 665 | — | — | May 19, 2026 |
No analyst notes on AMGN yet.
Analyst Ratings
29 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 4 | 8 | 17 | 3 | 2 | Hold2.74 |
| 1 mo ago | 4 | 8 | 17 | 3 | 2 | Hold2.74 |
| 2 mo ago | 4 | 10 | 16 | 2 | 2 | Hold2.65 |
| 3 mo ago | 4 | 10 | 17 | 2 | 1 | Hold2.59 |
Members whose judged calls on AMGN have played out most reliably.
No settled calls on AMGN yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice